QIAGEN powered by

Mitigating Variability in Somatic Variant Interpretation: An Expert Panel – Sep. 30

Date: 2022/09/30 Duration: 01:00:00 Presented by: Jenni Fairley, PhD Deputy Scheme Director, Molecular Pathology GenQA; Beth Pitel, MS, CG(ASCP)CM Clinical Variant Scientist, Department of Laboratory Medicine & Pathology Mayo Clinic; Kathryn Bungartz, PhD Professional Clinical Solutions Manager Qiagen Digital Insights; Sheryl Elkin, PhD Chief Scientific Officer Qiagen Digital Insights, Oncology

Inconsistencies in variant interpretation among laboratories can create confusion for clinicians and their patients, leaving them unable to confidently use genetic information to manage healthcare decisions. In this live panel discussion, experts in NGS testing and clinical informatics explore the issues surrounding the standardization of variant interpretation and consider how interpretation guidelines and clinical decision support (CDS) software can help to mitigate variability between laboratories.

Topics of discussion include:

  • Findings of a peer-reviewed study comparing the accuracy and consistency of variant assessments from commercial CDS software to the internal variant interpretation methods of eight laboratories.
  • Causes of inter-laboratory inconsistency in variant interpretation and how to mitigate variability.
  • The benefits of having an up-to-date, high-quality knowledge base to produce consistent, evidence-based clinical classifications.

Click here to register.